Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.
Health Catalyst, Inc. (HCAT) delivers data analytics and technology solutions that empower healthcare organizations to improve clinical outcomes. This page serves as a comprehensive resource for investors and industry professionals tracking the company’s strategic developments.
Key updates include earnings reports, product launches, leadership changes, and partnership announcements. Users will find verified press releases and curated news articles covering HCAT’s technology innovations, client expansions, and financial performance.
Regular updates feature developments in healthcare data warehousing, cloud analytics platforms, and professional service offerings. Content highlights operational milestones, regulatory compliance achievements, and market expansion efforts within the healthcare IT sector.
Bookmark this page to monitor Health Catalyst’s progress in enabling data-driven care improvements through its adaptive data architecture and analytics expertise. Check back for objective reporting on HCAT’s role in advancing healthcare interoperability and operational efficiency.
Health Catalyst (Nasdaq: HCAT) reported Q2 2022 financial results, achieving total revenue of $70.6 million, an 18% year-over-year increase. Technology revenue rose 28% to $45.4 million, while professional services revenue grew 5% to $25.2 million. Despite this, the company revised its full-year revenue and Adjusted EBITDA outlook downwards due to a challenging market environment impacting bookings. However, Health Catalyst remains focused on financial discipline and expects improved Adjusted EBITDA leverage in 2023.
Health Catalyst (Nasdaq: HCAT) partners with LifePoint Health to improve quality in patient care using data analytics technology. This multi-year collaboration aims to enhance LifePoint's National Quality Program by leveraging Health Catalyst's Data Operating System and other analytical tools. The partnership is set to reduce clinical outcome variations and improve decision-making across LifePoint's network of 63 hospitals and additional care sites. Both companies emphasize their commitment to data-driven approaches in healthcare delivery.
Health Catalyst (Nasdaq: HCAT) has announced a multi-year strategic partnership with Akron Children's Hospital, enhancing its analytics platform to improve pediatric care. The collaboration aims to boost patient experiences and operational efficiency using Health Catalyst's advanced analytics tools. Key offerings include the Data Operating System and various analytics applications to support Akron Children's Health Collaborative in enhancing child health and operational outcomes across two hospitals serving over 287,000 children annually.
Health Catalyst, a leader in data and analytics technology for healthcare, will announce its second quarter 2022 operating results on August 4, 2022, after market close. The company will also conduct a conference call at 5 p.m. E.T. the same day to discuss the results. Health Catalyst offers a cloud-based platform utilized by healthcare organizations to drive data-informed decisions, drawing from over 100 million patient records to enhance clinical, financial, and operational outcomes.
Health Catalyst (HCAT) has partnered with MemorialCare to implement Twistle, a patient engagement technology aimed at improving care for pediatric cardiology patients. This collaboration allows MemorialCare to remotely monitor patient progress and enhance communication between caregivers and families. MemorialCare serves over 8,000 children annually, providing specialized care and pediatric expertise. This partnership is expected to elevate patient outcomes significantly, aligning with Health Catalyst's vision of data-informed healthcare.
Health Catalyst (Nasdaq: HCAT) has announced the selection of its PowerCosting™ analytics application by Carle Health to enhance financial transformation efforts. This collaboration builds on an existing partnership aimed at improving clinical, operational, and financial performance. Carle Health, based in Urbana, Illinois, operates a comprehensive healthcare system including five hospitals and over 1,000 healthcare professionals. The integration of Health Catalyst's Data Operating System (DOS™) will provide insights into the true cost of care, aiding in better decision-making and operational efficiency.
Health Catalyst, Inc. (Nasdaq: HCAT) announced that it has documented over 5.4 million lives positively impacted by its initiatives, leading to $1.5 billion in validated improvements across 300 case studies. The company emphasizes its role in addressing the healthcare waste crisis, estimated between $760 billion and $935 billion. As of June 23, 2022, it has built a robust base of over 400 healthcare organizations that utilize its data and analytics technology for performance enhancements in clinical, operational, and financial outcomes.
Health Catalyst, a leader in data and analytics technology for healthcare, announced participation in two key investor conferences. CFO Bryan Hunt and SVP Adam Brown will present at William Blair’s 42nd Annual Growth Stock Conference in Chicago on June 7, 2022, at 12:40 pm CT, and at the Stifel Cross-Sector Insight Conference in Boston on June 8, 2022, at 3:35 pm ET. Health Catalyst's cloud-based platform leverages over 100 million patient records to drive data-informed healthcare improvements.
Health Catalyst (HCAT) has acquired ARMUS Corporation, a Silicon Valley firm specializing in clinical registry development and data management. This acquisition aims to enhance Health Catalyst's Clinical Quality and Outsourced Services offerings by integrating ARMUS's technology with its own Data Operating System (DOS™). Health Catalyst expects this strategic move to streamline operations for healthcare organizations and deliver significant financial savings. The collaboration promises to advance data abstraction and registry reporting capabilities, addressing the increasing demand for data-driven insights in healthcare.
Health Catalyst, Inc. (HCAT) reported Q1 2022 financial results, showing a 22% year-over-year revenue increase to $68.1 million, exceeding guidance. Adjusted EBITDA reached $671,000, a significant turnaround from a $(837,000) loss a year prior. Technology revenue rose 25% to $42.2 million, while professional services revenue grew 17% to $25.9 million. The net loss decreased by 21% to $22.5 million, highlighting improved operational efficiency amid labor market challenges. The company aims for continued growth and stability as it marks its third year as a public entity.
FAQ
What is the current stock price of Health Catalyst (HCAT)?
What is the market cap of Health Catalyst (HCAT)?
